[DOI] [PubMed] [Google Scholar] 142.Okuyama T., Shirakawa J., Tajima K., Ino Y., Vethe H., Togashi Y., Kyohara M., Inoue R., Miyashita D., Li J., et al
Glutathione IV therapy bypasses the digestive system, delivering antioxidants directly into the bloodstream for near-100% bioavailability
The researchers reported higher MTT assay signals, more cell movement, more tube-like network formation, higher VEGF-A expression, and increased ERK1/2 phosphorylation after BPC-157 exposure
Studies conducted over 40 weeks show that symptoms often decrease throughout treatment continues, though some patients may choose to discontinue treatment due to persistent symptoms
14-Day course of treatment
Genet 70 , 488495 (2006)